ORION CORPORATION STOCK EXCHANGE RELEASE 31 JUL 2012 AT 9.20 EEST
Orion Corporation will publish its financial result for 2012 on Tuesday, 5 February 2013.
The publication dates of the Interim Reports in 2013 are as follows:
Interim Report 1-3/2013 Tuesday, 23 April 2013
Interim Report 1-6/2013 Tuesday, 30 July 2013
Interim Report 1-9/2013 Tuesday, 22 October 2013
The Annual Report 2012 will be published on the company's website latest on week 9/2013.
The Annual General Meeting is planned to be held on Tuesday, 19 March 2013 in Helsinki.
Orion's financial reports and related presentation material are available on the Group's website at www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for publications and releases.
Orion Corporation
Timo Lappalainen Jari Karlson
President and CEO CFO
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo
www.orion.fi/en
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler® pulmonary drugs.
Orion's net sales in 2011 amounted to EUR 918 million and the company had about 3,400 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.